Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

BRISTOL-MYERS SQUIBB COMPANY

Filed by AVENUE SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-03 06:26:12 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
00687853-7527-4929-b0a3-596007d5fb28
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to prescription drugs, including 340B program

MMM · Medicare/Medicaid

Issues related to prescription drugs; Issues related to Senate Finance Dear Colleague process; Issues related to the Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the Orphan Cures Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; S. 3019, No Big Blockbuster Bailouts Act (NOBBBA); Issues related to Most Favored Nation (MFN)

Literal federal measure citations: H.R. 4299, S. 3019

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.